blurred vision; poor appetite; pain; fever; chills; Fatigue/ Exhaustion; Reduced mobility/ Poor mobility; muscle weakness/ Weakness in hands, legs; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An 81-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 12Jun2023 at 13:00 as dose 6 (booster), single (Lot number: GJ6748) intramuscular, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Thyroid cancer" (ongoing), notes: At Age 47; "Hypertension", start date: 2003 (ongoing); "GERD", start date: 2003 (ongoing); "Cornea Transplants", start date: 2004 (not ongoing), notes: I have cornea transplants: 2004 & 2016 (I am visually impaired); "Cornea Transplants", start date: 2016 (not ongoing), notes: I have cornea transplants: 2004 & 2016 (I am visually impaired); "Hypothyroidism", start date: 1962 (ongoing); "Surgical remove benign polyps", start date: 1962 (not ongoing); "Thyroidectomy", start date: 2003 (not ongoing), notes: Surgery for papillary cancer; "papillary cancer" (unspecified if ongoing); "Parotid gland cancer", start date: 2002 (ongoing); "TIA", start date: 2003, stop date: 2004, notes: Stroke following thyroid cancer surgery; "Meningioma", start date: 2004 (ongoing), notes: Asymptomatic brain tumor; "compression Fracture L-one", start date: 09Nov2018 (ongoing), notes: Air bag injury 09Nov2018; "Bulging disc", start date: 09Nov2018 (ongoing); "Air bag injury", start date: 09Nov2018 (unspecified if ongoing); "Fracture left wrist 2013 due to osteopenia", start date: 2013 (unspecified if ongoing), notes: Did not receive preventative back brace at discharge from Dr; "Fracture left wrist 2013 due to osteopenia onset 2010", start date: 2010 (unspecified if ongoing); "Osteoporosis" (ongoing), notes: Fracture left wrist 2013 due to osteopenia onset 2010. Did not receive treat to prevent osteoporosis; "visually impaired" (unspecified if ongoing), notes: I have cornea transplants: 2004 & 2016 (I am visually impaired); "Aspirin allergy", start date: 2004, stop date: 2010, notes: Stomach polyps due to aspirin allergy I did not know I had; "Stomach polyps", start date: 2004, stop date: 2010; "benign polyps" (unspecified if ongoing). Concomitant medication(s) included: LOSARTAN oral taken for hypertension, start date: 2003 (ongoing); PRILOSEC [OMEPRAZOLE] oral taken for gastrooesophageal reflux disease, start date: 2003 (ongoing); PREDNISOLONE ophthalmic taken for corneal transplant, start date: 2004 (ongoing); ALPHAGAN ophthalmic taken for corneal transplant, start date: 2004 (ongoing); CALCIUM oral taken for supplementation therapy, start date: 2020 (ongoing); CALCITRIOL taken for supplementation therapy, start date: 2022 (ongoing); LEVOTHYROXINE oral taken for thyroid hormone replacement therapy, thyroid cancer (ongoing). Vaccination history included: BNT162b2 (DOSE 1, SINGLE, Batch/Lot number : EN6202, Route of administration: Intramuscular), administration date: 25Feb2021, for COVID-19 Immunisation, reaction(s): "tooth reinfection/got infected in 2018 and it was like a slow infection, started prior to the vaccine, states it was reinfected between the two doses", "got infected in 2018 and it was like a slow infection, started prior to the vaccine, states it was reinfected between the two doses", "fever and chills", "fever and chills"; BNT162b2 (DOSE 2, SINGLE, Batch/Lot number: ER2613, Route of administration: Intramuscular, Anatomical location: Right arm), administration date: 18Mar2021, for COVID-19 Immunisation, reaction(s): "jaw infection", "Tooth reinfected between the two doses", "Fever", "chills", "TSH score for Thyroid is still low", "tooth problem", "She didn't feel well", "I am tired"; Covid-19 vaccine (DOSE 3 (BOOSTER); MANUFACTURER UNKNOWN), for COVID-19 Immunisation; Covid-19 vaccine (DOSE 4 (BOOSTER); MANUFACTURER UNKNOWN), for COVID-19 Immunisation; Covid-19 vaccine (DOSE 5 (BOOSTER); MANUFACTURER UNKNOWN), for COVID-19 Immunisation. The following information was reported: MOBILITY DECREASED (disability) with onset 12Jun2023 at 07:30, outcome "not recovered", described as "Reduced mobility/ Poor mobility"; MUSCULAR WEAKNESS (disability) with onset 12Jun2023 at 07:30, outcome "not recovered", described as "muscle weakness/ Weakness in hands, legs"; FATIGUE (disability) with onset 12Jun2023 at 20:30, outcome "not recovered", described as "Fatigue/ Exhaustion"; CHILLS (disability) with onset 12Jun2023 at 20:30, outcome "not recovered"; PYREXIA (disability) with onset 13Jun2023 at 04:30, outcome "not recovered", described as "fever"; PAIN (disability) with onset 13Jun2023 at 07:30, outcome "not recovered"; DECREASED APPETITE (disability) with onset 14Jun2023, outcome "not recovered", described as "poor appetite"; VISION BLURRED (disability) with onset 15Jun2023, outcome "not recovered", described as "blurred vision". The patient underwent the following laboratory tests and procedures: Body temperature: (12Jun2023) 100.3 degree; (13Jun2023) 99.4 degree; (14Jun2023) 98.6 degree. Therapeutic measures (Tylenol 500mg) were taken as a result of pyrexia. Clinical course: Prolonged symptoms not had in previous boosters.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021569172 Same patient/product, different dose/events (Dose 2);US-PFIZER INC-2021576957 Same patient/product, different dose/events (Dose 1);